Dual-energy X-ray absorptiometry is a valid method to estimatimate visceral adipose tissue in adult patients with Prader-Willi syndrome during treatment with growth hormone

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 9, 2014, Pages E1727-E1731

  Olarescu, Nicoleta Cristina ^a,b   Jørgensen, Anders Palmstrøm ^a   Godang, Kristin ^a   Jurik, Anne Grethe ^d   Frøslie, Kathrine Frey ^c   Bollerslev, Jens ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; GROWTH HORMONE; LEPTIN; LIPID; SOMATOMEDIN C; GLUCOSE BLOOD LEVEL; HUMAN GROWTH HORMONE;

ADULT; ARTICLE; BLOOD PRESSURE; BODY FAT DISTRIBUTION; BODY MASS; BODY WEIGHT; CARDIOMETABOLIC RISK; CLINICAL ARTICLE; CLINICAL TRIAL (TOPIC); COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATIONAL STUDY; DENSITOMETER; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GLUCOSE METABOLISM; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HORMONAL THERAPY; HUMAN; IMAGING SOFTWARE; INSULIN RELEASE; INSULIN RESISTANCE; INTERMETHOD COMPARISON; INTRAABDOMINAL FAT; LIPID STORAGE; MALE; MEASUREMENT ACCURACY; METABOLIC PARAMETERS; MULTICENTER STUDY (TOPIC); NORWEGIAN (PEOPLE); PRADER WILLI SYNDROME; RISK ASSESSMENT; SUBCUTANEOUS FAT; WAIST CIRCUMFERENCE; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; GLUCOSE BLOOD LEVEL; METABOLISM; MULTICENTER STUDY; PHOTON ABSORPTIOMETRY; PRADER-WILLI SYNDROME; PROCEDURES; RADIOGRAPHY; REPRODUCIBILITY; STANDARD; STANDARDS; VALIDATION STUDY; YOUNG ADULT;

ABSORPTIOMETRY, PHOTON; ADIPOKINES; ADULT; BLOOD GLUCOSE; DOUBLE-BLIND METHOD; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INTRA-ABDOMINAL FAT; MALE; PRADER-WILLI SYNDROME; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; RISK ADJUSTMENT; YOUNG ADULT;

EID: 84907203417     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-2059     Document Type: Article

References (22)

1. Goldstone AP, Holland AJ, Hauffa BP, Hokken-Koelega AC, Tauber M, speakers contributors at the Second Expert Meeting of the Comprehensive Care of Patients with PWS. Recommendations for the diagnosis and management of Prader-Willi syndrome. J Clin Endocrinol Metab. 2008;93(11):4183-4197.
2. Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444(7121):881-887.
3. Sode-Carlsen R, Farholt S, Rabben KF, et al. Body composition, endocrine and metabolic profiles in adults with Prader-Willi syndrome. Growth Horm IGF Res. 2010;20(3):179-184.
4. Britton KA, Massaro JM, Murabito JM, Kreger BE, Hoffmann U, Fox CS. Body fat distribution, incident cardiovascular disease, cancer, and all-cause mortality. J Am Coll Cardiol. 2013;62(10):921-925.
5. Tchernof A, Despres JP. Pathophysiology of human visceral obesity: an update. Physiol Rev. 2013;93(1):359-404.
6. Despres JP, Moorjani S, Lupien PJ, Tremblay A, Nadeau A, Bouchard C. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis. 1990;10(4):497-511.
7. Berryman DE, Glad CA, List EO, Johannsson G. The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations. Nat Rev Endocrinol. 2013;9(6):346-356.
8. Shuster A, Patlas M, Pinthus JH, Mourtzakis M. The clinical importance of visceral adiposity: a critical review of methods for visceral adipose tissue analysis. Br J Radiol. 2012;85(1009):1-10.
9. Kaul S, Rothney MP, Peters DM, et al. Dual-energy X-ray absorptiometry for quantification of visceral fat. Obesity (Silver Spring). 2012;20(6):1313-1318.
10. Ergun DL, Rothney MP, Oates MK, Xia Y, Wacker WK, Binkley NC. Visceral adipose tissue quantification using Lunar Prodigy. J Clin Densitom. 2013;16(1):75-78.
11. Xia Y, Ergun DL, Wacker WK, Wang X, Davis CE, Kaul S. Relationship between dual-energy X-ray absorptiometry volumetric assessment and X-ray computed tomography-derived single-slice measurement of visceral fat. J Clin Densitom. 2014;17(1):78-83.
12. Jorgensen AP, Ueland T, Sode-Carlsen R, et al. Glucose homeostasis in adults with Prader-Willi syndrome during treatment with growth hormone: results from a 12-month prospective study. Growth Horm IGF Res. 2014;24(1):16-21.
13. Jorgensen AP, Ueland T, Sode-Carlsen R, et al. Two years of growth hormone treatment in adults with Prader-Willi syndrome do not improve the lowBMD.J Clin Endocrinol Metab. 2013;98(4):E753-E760.
14. Sode-Carlsen R, Farholt S, Rabben KF, et al. One year of growth hormone treatment in adults with Prader-Willi syndrome improves body composition: results from a randomized, placebo-controlled study. J Clin Endocrinol Metab. 2010;95(11):4943-4950.
15. Sode-Carlsen R, Farholt S, Rabben KF, et al. Growth hormone treatment for two years is safe and effective in adults with Prader-Willi syndrome. Growth Horm IGF Res. 2011;21(4):185-190.
16. Godang K, Qvigstad E, Voldner N, et al. Assessing body composition in healthy newborn infants: reliability of dual-energy x-ray absorptiometry. J Clin Densitom. 2010;13(2):151-160.
17. Oldroyd B, Smith AH, Truscott JG. Cross-calibration of GE/Lunar pencil and fan-beam dual energy densitometers-bone mineral density and body composition studies. Eur J Clin Nutr. 2003;57(8): 977-987.
18. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27(6):1487-1495.
19. Sanchez-Ortiga R, Klibanski A, Tritos NA. Effects of recombinant human growth hormone therapy in adults with Prader-Willi syndrome: a meta-analysis. Clin Endocrinol (Oxf). 2012;77(1):86-93.
20. Talebizadeh ZI, Butler MG. Insulin resistance and obesity-related factors in Prader-Willi syndrome: comparison with obese subjects. Clin Genet. 2005;67(3):230-239.
21. Tseng YH, Butte AJ, Kokkotou E, et al. Prediction of preadipocyte differentiation by gene expression reveals role of insulin receptor substrates and necdin. Nat Cell Biol. 2005;7(6):601-611.
22. Hocking S, Samocha-Bonet D, Milner KL, Greenfield JR, Chisholm DJ. Adiposity and insulin resistance in humans: the role of the different tissue and cellular lipid depots. Endocr Rev. 2013;34(4):463-500.